We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · January 14, 2021

Efficacy of Enzalutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread

The Journal of Urology

 

Additional Info

The Journal of Urology
Efficacy of Enzalutamide Plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
J Urol 2020 Dec 28;[EPub Ahead of Print], AJ Armstrong, ND Shore, RZ Szmulewitz, DP Petrylak, J Holzbeierlein, A Villers, A Azad, A Alcaraz, B Alekseev, T Iguchi, F Gomez-Veiga, B Rosbrook, HJ Lee, GP Haas, A Stenzl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading